Partial
Mostly Aligned
Patient Risk:
Low
Summary
The AI-generated claims largely align on mechanism, common adverse effects, and key safety, monitoring, and drug-interaction themes described in the label. However, numerous indication-related claims (e.g., heart failure, post-MI, diabetic nephropathy), brand-name listing, and several marketing-style statements are not supported by the provided label. Overall, the output is partially aligned with substantial unsupported or absent-from-label items.
Category Scores
Accurate Statements
Lisinopril is a generic medication that belongs to the class of ACE inhibitors.
Mechanism of Action
Lisinopril works by blocking the conversion of angiotensin I to angiotensin II, a powerful blood-pressure-raising hormone.
Mechanism of Action
By reducing angiotensin II levels, it lowers blood pressure.
Mechanism of Action
Hypertension (high blood pressure) – most common indication.
Indications and Usage
Typically taken once daily, with or without food.
Dosage and Administration
The dose is individualized by your healthcare provider based on blood pressure, kidney function, and other health factors.
Dosage and Administration
Persistent dry cough.
Adverse Reactions
Dizziness or light‑headedness (especially when first starting the drug).
Adverse Reactions
Elevated potassium levels (hyperkalemia).
Mechanism of Action
Low blood pressure (especially after standing up quickly).
Adverse Reactions
Rarely, angioedema (swelling of the face, lips, tongue, or throat).
Warnings
Pregnancy – lisinopril is contraindicated (can harm the fetus).
Use in Pregnancy
Kidney function – dosage may need adjustment; frequent monitoring of creatinine and potassium is important.
Use in Renal Impairment
Interactions – can increase potassium when taken with potassium supplements or potassium‑sparing diuretics; can interact with NSAIDs and other blood‑pressure medications.
Drug Interactions
Keep regular follow‑up appointments to monitor blood pressure and kidney function.
Information for Patients
Report any new or worsening swelling, trouble breathing, or severe dizziness to your doctor immediately.
Information for Patients
Avoid salt substitutes containing potassium unless your doctor specifically recommends it.
Information for Patients
If you’re prescribed lisinopril or have questions about it, your pharmacist or doctor can give you specific dosing instructions and help monitor any potential side effects.
Dosage and Administration; Information for Patients
Unsupported Statements
Prinivil® and Zestril® are brand names for lisinopril.
Brand names are not typically listed in the label; the provided label excerpt does not explicitly list brand names.
By reducing angiotensin‑II levels, it decreases the strain on the heart.
Not explicitly stated as such in Indications/Mechanism; not direct wording in label.
By reducing angiotensin‑II levels, it can improve kidney function in people with certain types of kidney disease.
Label discusses renal protection in specific contexts but does not frame as generalized 'improve function' for all kidney disease.
Heart failure – to improve symptoms and reduce hospitalizations.
May appear in lisinopril labeling generally, but not clearly present in this label edition's Indications and Usage excerpt.
Post‑myocardial infarction (heart attack) – to improve survival and heart function.
Not clearly present in this label edition's Indications and Usage excerpt.
Diabetic nephropathy – to protect kidney function.
Not clearly present in this label edition's Indications and Usage excerpt.
It’s available in tablets (often 5 mg, 10 mg, 20 mg, 40 mg, or 80 mg) and in a dissolvable form for those who have trouble swallowing pills.
How Supplied section in this label excerpt lists specific tablet strengths but does not mention a dissolvable/orodispersible form.
In short, generic lisinopril is a versatile, widely used blood‑pressure medication that helps the heart work better and protects the kidneys.
Marketing-style summary not present in label language.
It’s typically prescribed once daily and works by dampening the body’s “fight‑or‑flight” hormone that raises blood pressure.
Mechanism described as ACE inhibition in label; not phrased as 'fight‑or‑flight' hormone.
Contradictions
Important Omissions
Brand names listed for lisinopril is not in label; marketing names are not typically in the label.
Importance:
Moderate
Dissolvable/orodispersible form not supported by How Supplied in this edition.
Importance:
Moderate
Boxed warning content for pregnancy is implied but not shown as a separate boxed warning in the provided sections.
Importance:
High
Heart failure and post‑MI indications for lisinopril monotherapy are not clearly supported in this label edition and are listed as absent_from_label.
Importance:
Moderate
Diabetic nephropathy as an indication is not clearly supported in this label edition.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The claims align with common safety concerns (cough, hyperkalemia, hypotension, angioedema, pregnancy contraindication) as described in the label; however, the presence of several unsupported indication claims introduces some safety/safety-communication risk if conveyed to patients.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Remove or flag brand-name and marketing-style statements not supported by the label; restrict indications to those supported (hypertension, and those clearly present in this label edition).
Suggested Improvement
Limit claims to label-supported indications (hypertension; and any other indications explicitly listed in this edition). Omit branding references and form factors not described in the label. For remaining dosing guidance, ensure concordance with the label's dosage, renal impairment guidance, and monitoring recommendations; include explicit boxed warning language if applicable, and avoid implying broader 'kidney function improvement' or 'fight‑or‑flight' mechanism wording.